The Science of Scaling

Isn’t it strange that a startup’s likelihood of failure hardly changes as they mature from Series A to Series B and beyond? You would think the odds improve as a firm matures and achieves significant milestones…

Kjael Skaalerud, CRO at Altvia, is joined by Mark Roberge, Co-Founder of Stage 2 Capital, a venture fund focused on enabling go-to-market (GTM) execution for early stage firms. Stage 2 is fixated on reducing failure rates as a firm scales by leveraging an LP base made up of renowned GTM leaders to inform when to scale, and how fast. Mark himself is the former CRO of Hubspot, where he helped lead the firm from pre revenue to IPO.

Tune in to learn more about Mark’s story, the thesis for Stage 2, and perhaps get a sneak peak into a venture operating model that challenges a range of conventional thinking, in an industry that hasn’t changed much the last twenty years.